Bank of America’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4
Closed -$13 6750
2025
Q4
$13 Sell
4
-7
-64% -$63 ﹤0.01% 7180
2025
Q3
$120 Sell
11
-364
-97% -$4.22K ﹤0.01% 7820
2025
Q2
$8.24K Buy
375
+371
+9,275% +$9.15K ﹤0.01% 7225
2025
Q1
$153 Buy
4
+1
+33% +$48 ﹤0.01% 7746
2024
Q4
$196 Buy
3
+2
+200% +$119 ﹤0.01% 7590
2024
Q3
$52 Hold
1
﹤0.01% 7835
2024
Q2
$189 Buy
+1
New +$109 ﹤0.01% 7570
2024
Q1
Hold
0
-$18 8149
2023
Q4
Hold
0
7670
2021
Q3
Hold
0
8371
2021
Q2
Hold
0
8062
2021
Q1
Hold
0
7746
2020
Q4
Hold
0
7347
2020
Q3
Sell
-7
Closed -$11.3K 7148
2020
Q2
$11K Buy
7
+6
+600% +$9.58K ﹤0.01% 6423
2020
Q1
$1K Hold
1
﹤0.01% 6736
2019
Q4
$7K Hold
1
﹤0.01% 6710
2019
Q3
$3K Buy
+1
New +$15.3K ﹤0.01% 6946
2019
Q2
Hold
0
6750

Other funds holding SONM

Bank of America's SONM Position: Q1 2026 in Review

Bank of America sold out of DNA X Inc (SONM) in Q1 2026, closing a stake of 4 shares — an estimated $13 sold.

Bank of America first reported a position in SONM in Q3 2019 and held it in 11 quarters. The position peaked at $11K in Q2 2020. 9 funds tracked by Wall St. Rank hold SONM as of Q1 2026.

  • Bank of America reported no remaining DNA X Inc position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 4 DNA X Inc shares in Q1 2026, an estimated $13.
  • Bank of America first reported a position in DNA X Inc in Q3 2019 and held it in 11 quarters.
  • Bank of America's DNA X Inc position peaked at $11K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.